← back to search

Hongyu Zhang

Long Island University · US
Area of research
Hematology · Pathology and Forensic Medicine
Research interest
Research interests include Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment, Immune Cell Function and Interaction, and Histone Deacetylase Inhibitors Research.
h-index
27
citations
2,443
works
143
NIH funding
primary concept
email

Recent publications

Going Beyond Surface Physics: Interface Engineering of <scp>PTAA</scp> for Efficient p‐i‐n Perovskite Photovoltaics
Energy & environment materials 2025cited by 4position: middledoi
Avatrombopag improves platelet engraftment after haploidentical hematopoietic stem cell transplantation: A randomized, double-blind, multicenter, placebo-controlled trial
Blood 2025cited by 0position: middledoi
Sorafenib plus triplet therapy with venetoclax, azacitidine and homoharringtonine for refractory/relapsed acute myeloid leukemia with <i>FLT3‐ITD</i>: A multicenter phase 2 study
Journal of Internal Medicine 2023cited by 22position: middledoi
Basiliximab for steroid‐refractory acute graft‐versus‐host disease: A real‐world analysis
American Journal of Hematology 2022cited by 58position: middledoi
Genetic characteristics predict response to venetoclax plus hypomethylating agents in relapsed or refractory acute myeloid leukemia
Journal of Internal Medicine 2022cited by 44position: middledoi
Prednisone plus IVIg compared with prednisone or IVIg for immune thrombocytopenia in pregnancy: a national retrospective cohort study
Therapeutic Advances in Hematology 2022cited by 15position: middledoi
A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China
Frontiers in Oncology 2021cited by 21position: middledoi
Prediction of postpartum hemorrhage in pregnant women with immune thrombocytopenia: Development and validation of the <scp>MONITOR</scp> model in a nationwide multicenter study
American Journal of Hematology 2021cited by 13position: middledoi
Identification and validation of dichotomous immune subtypes based on intratumoral immune cells infiltration in clear cell renal cell carcinoma patients
Journal for ImmunoTherapy of Cancer 2020cited by 60position: middledoi
A risk score for predicting hospitalization for community-acquired pneumonia in ITP using nationally representative data
Blood Advances 2020cited by 6position: middledoi
Abstract CT041: The efficacy and safety of Geptanolimab (GB226) in patients with relapsed/refractory peripheral T cell lymphoma (PTCL): A multicenter, open-label, single-arm, phase 2 trial
Cancer Research 2020cited by 0position: middledoi
KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma
Cancer Immunology Immunotherapy 2017cited by 292position: middledoi
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
Journal of Hematology & Oncology 2017cited by 251position: middledoi
Uterine Leiomyomas: Safety and Efficacy of US-guided Suprapubic Transvaginal Radiofrequency Ablation at 1-year Follow-up
Radiology 2015cited by 22position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yu Zhang · Harbin Medical University2 papers (2022–2023)Na Xu · Tongji Hospital2 papers (2022–2023)Xinquan Liang · Shandong Provincial QianFoShan Hospital2 papers (2022–2023)Zhiqiang Sun · Chinese PLA General Hospital2 papers (2022–2023)Hua Jin · Nathan Kline Institute for Psychiatric Research2 papers (2022–2023)Sijian Yu · Southern Medical University2 papers (2022–2023)Ziwen Guo · The First Affiliated Hospital, Sun Yat-sen University2 papers (2022–2023)Ruoyang Shao · Southern Medical University2 papers (2022–2023)Jie Xiao · South China Agricultural University2 papers (2022–2023)Dongjun Lin · Sun Yat-sen University2 papers (2022–2023)Lan Deng · Tianjin Agricultural University2 papers (2022–2023)Guopan Yu · Jinan University2 papers (2022–2023) · 1 papers (2025–2025)Li Zhang · Peking University1 papers (2017–2017)Xiong Zhang · Hebei Medical University1 papers (2023–2023)Nan Chen · Beijing Institute of Technology1 papers (2017–2017)Yu Wang · Affiliated Hospital of Liaoning University of Traditional Chinese Medicine1 papers (2023–2023)Fei Wang · National University of Singapore1 papers (2025–2025)Yuhong Chen · National Kaohsiung First University of Science and Technology1 papers (2025–2025)Chen‐Hua Yan · Peking University1 papers (2025–2025)